The combination of autofluorescence endoscopy and molecular biomarkers is a novel diagnostic tool for dysplasia in Barrett's oesophagus

Conclusions
A three-biomarker panel on a small number of AFI-targeted biopsies provides an accurate and objective diagnosis of dysplasia in BO. The clinical implications have to be studied further.

Source: Gut - December 8, 2014 Category: Gastroenterology Authors: di Pietro, M., Boerwinkel, D. F., Shariff, M. K., Liu, X., Telakis, E., Lao-Sirieix, P., Walker, E., Couch, G., Mills, L., Nuckcheddy-Grant, T., Slininger, S., O'Donovan, M., Visser, M., Meijer, S. L., Kaye, P. V., Wernisch, L., Ragunath, K., Bergman, J. Tags: Open access, Oesophageal cancer Endoscopy Source Type: research